Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 19/20 | 0.72 |
| ▸ | PIK3R1 | P27986 | 17/20 | 0.72 |
| ▸ | PIK3CG | P48736 | 8/20 | 0.60 |
| ▸ | PIK3CB | P42338 | 6/20 | 0.60 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.60 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19251444 | 1.00 | PIK3CD (0.72) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19254009 | 0.93 | PIK3CD (0.63) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19251438 | 0.93 | PIK3CD (0.63) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19254017 | 0.92 | PIK3CD (0.62) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19251450 | 0.92 | PIK3CD (0.62) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19251440 | 0.90 | PIK3CD (0.59) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19254011 | 0.90 | PIK3CD (0.59) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19254019 | 0.85 | PIK3CD (0.61) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19251411 | 0.85 | PIK3CD (0.61) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA | |
| SCHEMBL19254010 | 0.84 | PIK3CD (0.60) | PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133655-A1 | BENZOTHIAZINE AND BENZOTHIADIAZINE COMPOUNDS AND PREPARATION AND USE | 浙江大学 | 2017-08-10 | — | — | WO | disclosed |